<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02869776</url>
  </required_header>
  <id_info>
    <org_study_id>H-35271</org_study_id>
    <secondary_id>RA25035163 -01A 1</secondary_id>
    <secondary_id>5P30AI042853-18</secondary_id>
    <nct_id>NCT02869776</nct_id>
  </id_info>
  <brief_title>Integrating HCV and HIV Screening During the Era of HIV Antigen Testing</brief_title>
  <official_title>Integrating HCV and HIV Screening During the Era of HIV Antigen Testing</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Allergy and Infectious Diseases (NIAID)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Boston Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this proposal is to develop an optimal testing strategy for HCV and HIV in
      high prevalence settings, such as detoxification centers with a large proportion of young
      injection drug users. The latest venipuncture testing will be compared to rapid finger stick
      testing for HCV and HIV. Outcomes for each strategy among individuals admitted at a
      short-term drug detoxification center will be determined.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>September 2016</start_date>
  <completion_date type="Anticipated">September 2020</completion_date>
  <primary_completion_date type="Actual">July 26, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of participants who receive HCV test results</measure>
    <time_frame>within 5 days (by the time of discharge from the detoxification center)</time_frame>
    <description>The number of participants who receive HCV test results by the time they are discharged from the detoxification center</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of participants who receive HIV test results</measure>
    <time_frame>within 5 days (by the time of discharge from the detoxification center)</time_frame>
    <description>The number of participants who receive HIV test results by the time they are discharged from the detoxification center</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of participants who link to HCV care</measure>
    <time_frame>by three months</time_frame>
    <description>The number of participants who are seen for an HCV visit</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants who have HCV RNA testing</measure>
    <time_frame>by three months</time_frame>
    <description>The number of participants who have HCV RNA testing performed</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants who have fibrosis staging performed</measure>
    <time_frame>by three months</time_frame>
    <description>The number participants who have fibrosis staging performed</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants who have HCV treatment initiated</measure>
    <time_frame>by six months</time_frame>
    <description>The number participants who have HCV treatment initiated</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants who reach sustained virologic response</measure>
    <time_frame>by twelve months</time_frame>
    <description>The number participants who reach sustained virologic response</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants who link to HIV care</measure>
    <time_frame>by 3 months</time_frame>
    <description>The number participants who are seen for an HIV visit</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants who HIV RNA testing</measure>
    <time_frame>by 3 months</time_frame>
    <description>The number participants who have HIV RNA testing</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants who have CD4 testing</measure>
    <time_frame>by 3 months</time_frame>
    <description>The number participants who have CD4 testing</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants who have antiretroviral treatment initiated</measure>
    <time_frame>by 3 months</time_frame>
    <description>The number participants who initiated antiretroviral treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants who achieve HIV viral suppression</measure>
    <time_frame>by 6 months</time_frame>
    <description>The number participants who achieve HIV viral suppression</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>HIV</condition>
  <condition>Hepatitis C</condition>
  <arm_group>
    <arm_group_label>Rapid finger stick</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>HIV and HCV testing through rapid finger stick. Behavioral questionnaires will also be administered.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard venipuncture</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>HIV and HCV testing through venipuncture. Behavioral questionnaires will also be administered.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Questionnaire</intervention_name>
    <description>Behavioral questionnaires</description>
    <arm_group_label>Rapid finger stick</arm_group_label>
    <arm_group_label>Standard venipuncture</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Rapid finger stick</intervention_name>
    <description>HIV and HCV testing through rapid finger stick</description>
    <arm_group_label>Rapid finger stick</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Venipuncture</intervention_name>
    <description>HIV and HCV testing through venipuncture</description>
    <arm_group_label>Standard venipuncture</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age greater or equal to 18

          -  All clients admitted to BTC with a history of drug or alcohol use

          -  Individuals who self-report as being HIV and HCV non-infected within the past 6 months
             or having unknown status

          -  Participants providing contact information of two family members or friends

          -  Individuals signing a medical records release form for the referral site (Boston
             Medical Center)

          -  English speaking

        Exclusion Criteria:

          -  Individuals unable to provide informed consent

          -  Individuals with a known history of HCV and/or HIV
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sabrina Assoumou, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Boston Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Boston Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02118</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 10, 2016</study_first_submitted>
  <study_first_submitted_qc>August 16, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 17, 2016</study_first_posted>
  <last_update_submitted>August 9, 2017</last_update_submitted>
  <last_update_submitted_qc>August 9, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 10, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Boston Medical Center</investigator_affiliation>
    <investigator_full_name>Sabrina Assoumou</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hepatitis C</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

